Inventor · disambiguated record
Liladhar Murlidhar Waykole
Also filed as: WAYKOLE LILADHAR · WAYKOLE LILADHAR M · WAYKOLE LILADHAR MURLIDHAR
23 granted patents·5 pending applications·80 citations·filing 2000–2024
93Inventor score
Top patents by PatentIndex Score
28 records- 0194US10947218B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2020·Granted Mar 16, 2021·6 cites·13 claims
- 0291US10710980B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·8 cites·6 claims
- 0391US6897307B2Process for preparing 2,6-diaminopurine derivativesNOVARTIS AG·Filed 2003·Granted May 24, 2005·34 cites·30 claims
- 0489US8115016B2Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acidHOOK DAVID·Filed 2008·Granted Feb 14, 2012·13 cites·16 claims
- 0577US9309229B2Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamineFENG LILI·Filed 2011·Granted Apr 12, 2016·3 cites·26 claims
- 0675US8993785B2Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acidHOOK DAVID·Filed 2014·Granted Mar 31, 2015·2 cites·15 claims
- 0775US6958331B1Bradykinin receptor antagonistsNOVARTIS AG·Filed 2000·Granted Oct 25, 2005·10 cites·9 claims
- 0872US2021253534A1Compositions and methods for modulating farnesoid x receptorsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0971US11021446B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2020·Granted Jun 1, 2021·0 cites·13 claims
- 1070US12466808B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 1169US9802931B2Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursorsNOVARTIS AG·Filed 2016·Granted Oct 31, 2017·1 cites·8 claims
- 1268US11548897B2Crystalline forms of a triazolopyrimidine compoundNOVARTIS AG·Filed 2021·Granted Jan 10, 2023·0 cites·4 claims
- 1367US9365565B2Salts of aza-bicyclic di-aryl ethers and pharmaceuticals thereofMARTERER WOLFGANG·Filed 2012·Granted Jun 14, 2016·2 cites·16 claims
- 1467US8063043B2Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamideBAJWA JOGINDER·Filed 2009·Granted Nov 22, 2011·1 cites·2 claims
- 1566US11590158B2Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using sameNOVARTIS AG·Filed 2021·Granted Feb 28, 2023·0 cites·24 claims
- 1663US11091489B2Crystalline forms of a triazolopyrimidine compoundNOVARTIS AG·Filed 2017·Granted Aug 17, 2021·0 cites·11 claims
- 1762US2025188054A1Crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancerNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1861US11135239B1Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using sameNOVARTIS AG·Filed 2021·Granted Oct 5, 2021·0 cites·30 claims
- 1958US10421755B2Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursorsNOVARTIS AG·Filed 2017·Granted Sep 24, 2019·0 cites·13 claims
- 2056US8716495B2Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acidHOOK DAVID·Filed 2011·Granted May 6, 2014·0 cites·30 claims
- 2154US12187703B2Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancerNOVARTIS AG·Filed 2020·Granted Jan 7, 2025·0 cites·16 claims
- 2252US9206116B2Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acidHOOK DAVID·Filed 2015·Granted Dec 8, 2015·0 cites·20 claims
- 2352US9181215B2Manufacturing process for pyrimidine derivativesDE LA CRUZ MARILYN·Filed 2011·Granted Nov 10, 2015·0 cites·13 claims
- 2451US2012214810A1Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamideBAJWA JOGINDER SINGH·Filed 2012·Application pending·0 cites
- 2548US10934273B2Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpicolinamideNOVARTIS AG·Filed 2017·Granted Mar 2, 2021·0 cites·14 claims
- 2648US2012035174A1Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamideBAJWA JOGINDER SINGH·Filed 2011·Application pending·0 cites
- 2743US2016175305A1Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamineFENG LILI·Filed 2016·Application pending·0 cites
- 2838US11786498B2Sacubitril calcium saltsNOVARTIS AG·Filed 2015·Granted Oct 17, 2023·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Liladhar Murlidhar Waykole files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →